A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder

Trial Profile

A Phase 1-b Non-blinded Study of Safety, Tolerability and Efficacy of Lorexys in Premenopausal Women With Hypoactive Sexual Desire Disorder

Completed
Phase of Trial: Phase I/II

Latest Information Update: 29 Oct 2014

At a glance

  • Drugs Bupropion/trazodone (Primary) ; Bupropion
  • Indications Decreased libido
  • Focus Therapeutic Use
  • Acronyms PURPLE
  • Most Recent Events

    • 27 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Mar 2014 Results data for the phase IIa part of this trial are expected in the second quarter of 2014, according to a S1 Biopharma media release.
    • 29 Jul 2013 Enrolment and dosing has been initiated in the phase IIa part of the study, and results data are expected in the first quarter of 2014, according to an S1 Biopharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top